The Cleveland Clinic received a nod from the American Heart Association for success in using the Get With the Guidelines treatment interventions.
Stay informed about heart, vascular and thoracic topics in this continuation of The Beating Edge blog from our Heart & Vascular Institute, which is ranked No. 1 in heart care in the nation by U.S. News & World Report.
Researchers continue to uncover ways genes influence or cause heart disease. But how best to use this information is not always clear.
When an electrical malfunction causes the heart to lose pumping power, cardiac resynchronization therapy can put the heart’s contractions back on track.
In the largest study of its kind, researchers find both a leaky mitral valve and AFib can be addressed successfully during the same surgery.
Two breakthroughs may get FDA approval in 2015: PCSK9 inhibitors, which can lower cholesterol without statins, and LCZ696, which may better treat heart failure.
Men who had up to seven alcoholic drinks per week had a 20 percent lower risk of heart failure, compared with those who didn’t drink, reports one study. But many questions remain.
Left ventricular assist devices help failing hearts pump better, and cardiac rehab improves both strength and quality of life for new recipients of LVADs.
Learn about three medical innovations that relate to the human heart, including the development of a small leadless pacemaker, new cholesterol-lowering injections and a new congestive heart failure drug.
Heart disease develops differently in women and men. Women respond better to cardiac resynchronization therapy, but many women aren't treated.